ESR1 and breast carcinoma: Its anticancer activity in hormone-dependent cancer, observed specifically in estrogen-dependent breast cancer cells, seems to be particularly interesting, as Kam can regulate the expression and function of estrogen receptor alpha (Erα) [9].